<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/verve-therapeutics-inc-logo-1200x675.jpg/query-dj0yMDI0MDUyMTA4NTkyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/verve-therapeutics-inc-logo-1200x675.jpg/query-dj0yMDI0MDUyMTA4NTkyMQ"/></p>
<p>Verve Therapeutics, Inc.（納斯達克代碼：VERV - 獲取免費報告）內部人士 Joan Nickerson 於 4 月 2 日星期三出售了 2,777 股該公司的股票。股票以平均價格 4.15 美元出售，總價值為 11,524.55 美元。出售完成後，該內部人士現在持有 17,420 股公司股票，價值 72,293 美元。這代表其持股減少了 13.75%。該交易在向美國證券交易委員會（SEC）提交的文件中披露，文件可通過此鏈接獲取。</p>
<h2>Verve Therapeutics 股票表現</h2>
<ul>
<li>Verve Therapeutics 在 6 月份上漲 20.74%，因 Ark 基金投資</li>
</ul>
<p>VERV 在週五開盤價為 3.85 美元。該公司的市值為 3.4186 億美元，市盈率為-1.57，貝塔值為 1.77。該公司的 50 日簡單移動平均線為 6.70 美元，200 日簡單移動平均線為 6.04 美元。Verve Therapeutics, Inc.的 12 個月低點為 3.68 美元，12 個月高點為 9.31 美元。</p>
<p>Verve Therapeutics（納斯達克代碼：VERV - 獲取免費報告）最近於 2 月 27 日星期四發佈了季度財報。公司報告每股收益為-0.58 美元，超過市場共識預期的-0.72 美元，超出 0.14 美元。該季度的收入為 1308 萬美元，而分析師預期為 394 萬美元。Verve Therapeutics 的淨利潤率為-807.65%，股本回報率為-35.23%。整體來看，賣方分析師預計 Verve Therapeutics, Inc.在當前財政年度將發佈-2.49 的每股收益。</p>
<h2>分析師設定新目標價</h2>
<hr/>
<hr/>
<p>VERV 已成為多份研究報告的主題。William Blair 在 2 月 21 日星期五的研究報告中重申了對 Verve Therapeutics 股票的 “跑贏大盤” 評級。HC Wainwright 在 3 月 25 日星期二的報告中重申了 “買入” 評級，並設定了 15.00 美元的目標價。Guggenheim 在 3 月 25 日星期二的研究報告中重申了對 Verve Therapeutics 股票的 “買入” 評級。最後，加拿大皇家銀行在 3 月 4 日星期二的研究報告中將 Verve Therapeutics 的目標價從 17.00 美元下調至 15.00 美元，並對該公司設定了 “跑贏大盤” 評級。五位分析師對該股票給予了買入評級，根據 MarketBeat 的數據，該公司目前的共識評級為 “買入”，平均目標價為 20.67 美元。</p>
<p><strong>查看我們對 VERV 的最新分析</strong></p>
<h2>機構投資者對 Verve Therapeutics 的看法</h2>
<p>一些對沖基金和其他機構投資者最近買入和賣出了 VERV 的股票。BVF Inc. IL 在第四季度將其在 Verve Therapeutics 的持股增加了 962.2%。BVF Inc. IL 現在擁有 6,904,050 股公司股票，價值 38,939,000 美元，在上個季度又購買了 6,254,050 股。Point72 Asset Management L.P.在第四季度購買了 Verve Therapeutics 的新頭寸，價值約為 7,863,000 美元。Schonfeld Strategic Advisors LLC 在第四季度將其在 Verve Therapeutics 的持股增加了 57.4%。Schonfeld Strategic Advisors LLC 現在擁有 3,789,379 股公司股票，價值 21,372,000 美元，在上個季度又購買了 1,382,176 股。State Street Corp 在第三季度將其在 Verve Therapeutics 的持股增加了 27.0%。State Street Corp 現在擁有 4,253,217 股公司股票，價值 20,586,000 美元，在上個季度又收購了 903,809 股。最後，Jacobs Levy Equity Management Inc.在第三季度將其在 Verve Therapeutics 的持股增加了 72.2%。Jacobs Levy Equity Management Inc.現在擁有 1,559,393 股公司股票，價值 7,547,000 美元，在上個季度又收購了 653,578 股。97.11% 的股票由機構投資者和對沖基金持有。</p>
<h2>關於 Verve Therapeutics</h2>
<p>（獲取免費報告）</p>
<p>Verve Therapeutics, Inc.是一家臨牀階段的基因治療公司，致力於開發基因編輯藥物，以治療美國的心血管疾病。該公司的主要產品候選藥物是 VERVE-101，這是一種單次基因編輯治療，能夠永久關閉肝臟中的 PCSK9 基因；以及 VERVE-102，這是一種針對 PCSK9 基因的產品候選藥物，用於治療家族性高膽固醇血癥（HeFH）。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票比 Verve Therapeutics 更好</li>
<li>三大醫療股息股票值得購買和持有</li>
<li>RH 的股票下跌近 40%：投資者現在可以轉向哪裏</li>
<li>如何使用 MarketBeat 股票篩選器</li>
<li>關税、分拆和 R2 更新是 Rivian 的積極信號</li>
<li>股票拆分意味着什麼？</li>
<li>Cathie Wood 大量購買百度——現在是購買的合適時機嗎？</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和來自 InsiderTrades.com 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 InsiderTrades.com 編輯團隊的審核。如對該故事有任何問題或意見，請發送電子郵件至 [email protected].</em></p>
<p>Verve Therapeutics 的內部買賣情況？</p>
<p>註冊以接收 InsiderTrades.com 關於 Verve Therapeutics 及相關公司的每日內部買賣報告。</p>
<p>來自 MarketBeat 的更多信息</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_elon_new-1.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_elon_new-1.jpg"/></p>
<p>DOGE 社會保障的重磅消息？</p>
<p>埃隆·馬斯克剛剛發佈了另一個重磅消息……他透露他的 DOGE 組織一直在瞄準社會……</p>
<p>Altimetry</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUwOQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUwOQ"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_Depositphotos_210423878_S.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_Depositphotos_210423878_S.jpg"/></p>
<p>7 只股票迎接自動駕駛熱潮</p>
<p>全球自動駕駛汽車（AV）市場正在增長。根據自動駕駛汽車行業協會的數據顯示……</p>
<p>MarketBeat</p>
<p><img src="https://imageproxy.pbkrs.com/https://3328.efuserassets.com/3328/offers/56/c/397/assets/PGC%20-%20Gold%20Guide%20Open%20Layout%20Mockup.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://3328.efuserassets.com/3328/offers/56/c/397/assets/PGC%20-%20Gold%20Guide%20Open%20Layout%20Mockup.png"/></p>
<p>你的退休金正處於交火之中</p>
<p>當特朗普於 2017 年上任時，黃金的價格僅為每盎司 1100 美元。到他離任時，價格飆升至 1839 美元。...</p>
<p>首選黃金公司</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjQyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjQyMQ"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2066push_Depositphotos_235981192_S.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2066push_Depositphotos_235981192_S.jpg"/></p>
<p>7 只酒類股票準備帶來利潤</p>
<p>在 2020 年和 2021 年，酒類股票是表現最好的消費品股票之一。但情況有所不同...</p>
<p>市場快訊</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_elon-musk-6222396_640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_elon-musk-6222396_640.jpg"/></p>
<p>每月從特斯拉的秘密股息中收取 7000 美元</p>
<p>特斯拉並不支付傳統股息....但我剛剛發現了一個秘密後門，可以收取秘密的 69...</p>
<p>投資者小巷</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUyMQ"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2068push_Depositphotos_42578405_S.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2068push_Depositphotos_42578405_S.jpg"/></p>
<p>7 只鈾股票可以為增長投資組合提供動力</p>
<p>投資商品股票可能很棘手，鈾股票也不例外。鈾的現貨價格...</p>
<p>市場快訊</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_bitcoin-3374479_640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_bitcoin-3374479_640.jpg"/></p>
<p>緊急比特幣警報，立即關注</p>
<p>前億萬富翁對沖基金經理拉里·本尼迪克特發佈了他最令人難以置信的演示文稿，內容涉及他的 4...</p>
<p>布朗斯通研究</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUwMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUwMQ"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2054push_stocks.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2054push_stocks.jpg"/></p>
<p>現在擁有的 7 只最佳股票</p>
<p>今天，我們邀請您查看我們為未來三十天推薦的七隻最佳股票。為什麼它們值得關注...</p>
<p>市場快訊</p>

VERV

<p>Verve Therapeutics, Inc.（納斯達克代碼：VERV）的內部人士 Joan Nickerson 以平均價格 4.15 美元出售了 2,777 股，總計 11,524.55 美元。出售後，她持有 17,420 股，估值約為 72,293 美元，持股比例減少了 13.75%。該交易已向美國證券交易委員會（SEC）披露。該公司的市值為 3.4186 億美元，季度每股收益（EPS）為（0.58 美元），超出預期。分析師維持一致的 “買入” 評級，平均目標價為 20.67 美元。機構投資者持有該股票的 97.11%</p>

<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/verve-therapeutics-inc-logo-1200x675.jpg/query-dj0yMDI0MDUyMTA4NTkyMQ" alt="" original-src="https://www.marketbeat.com/logos/verve-therapeutics-inc-logo-1200x675.jpg?v=20240521085921"/></p>
<p>Verve Therapeutics, Inc. (NASDAQ:VERV - Get Free Report) insider Joan Nickerson sold 2,777 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $4.15, for a total value of $11,524.55. Following the completion of the sale, the insider now owns 17,420 shares of the company's stock, valued at $72,293. This represents a 13.75 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.</p>
<div class="lb-trans"><p>Verve Therapeutics, Inc.（納斯達克代碼：VERV - 獲取免費報告）內部人士 Joan Nickerson 於 4 月 2 日星期三出售了 2,777 股該公司的股票。股票以平均價格 4.15 美元出售，總價值為 11,524.55 美元。出售完成後，該內部人士現在持有 17,420 股公司股票，價值 72,293 美元。這代表其持股減少了 13.75%。該交易在向美國證券交易委員會（SEC）提交的文件中披露，文件可通過此鏈接獲取。</p>
</div><h2>Verve Therapeutics Stock Performance</h2>
<div class="lb-trans"><h2>Verve Therapeutics 股票表現</h2>
</div><ul>
<li>Verve Therapeutics Gains 20.74% In June as Ark Funds Invest</li>
</ul>
<div class="lb-trans"><ul>
<li>Verve Therapeutics 在 6 月份上漲 20.74%，因 Ark 基金投資</li>
</ul>
</div><p>VERV opened at $3.85 on Friday. The firm has a market cap of $341.86 million, a price-to-earnings ratio of -1.57 and a beta of 1.77. The firm's 50-day simple moving average is $6.70 and its 200-day simple moving average is $6.04. Verve Therapeutics, Inc. has a twelve month low of $3.68 and a twelve month high of $9.31.</p>
<div class="lb-trans"><p>VERV 在週五開盤價為 3.85 美元。該公司的市值為 3.4186 億美元，市盈率為-1.57，貝塔值為 1.77。該公司的 50 日簡單移動平均線為 6.70 美元，200 日簡單移動平均線為 6.04 美元。Verve Therapeutics, Inc.的 12 個月低點為 3.68 美元，12 個月高點為 9.31 美元。</p>
</div><p>Verve Therapeutics (NASDAQ:VERV - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.58) earnings per share for the quarter, topping the consensus estimate of ($0.72) by $0.14. The firm had revenue of $13.08 million for the quarter, compared to analysts' expectations of $3.94 million. Verve Therapeutics had a negative net margin of 807.65% and a negative return on equity of 35.23%. As a group, sell-side analysts anticipate that Verve Therapeutics, Inc. will post -2.49 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Verve Therapeutics（納斯達克代碼：VERV - 獲取免費報告）最近於 2 月 27 日星期四發佈了季度財報。公司報告每股收益為-0.58 美元，超過市場共識預期的-0.72 美元，超出 0.14 美元。該季度的收入為 1308 萬美元，而分析師預期為 394 萬美元。Verve Therapeutics 的淨利潤率為-807.65%，股本回報率為-35.23%。整體來看，賣方分析師預計 Verve Therapeutics, Inc.在當前財政年度將發佈-2.49 的每股收益。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><hr/>
<div class="lb-trans"><hr/>
</div><hr/>
<div class="lb-trans"><hr/>
</div><p>VERV has been the subject of several research reports. William Blair reaffirmed an &#34;outperform&#34; rating on shares of Verve Therapeutics in a research report on Friday, February 21st. HC Wainwright reaffirmed a &#34;buy&#34; rating and set a $15.00 price objective on shares of Verve Therapeutics in a report on Tuesday, March 25th. Guggenheim reissued a &#34;buy&#34; rating on shares of Verve Therapeutics in a research note on Tuesday, March 25th. Finally, Royal Bank of Canada cut their price target on shares of Verve Therapeutics from $17.00 to $15.00 and set an &#34;outperform&#34; rating for the company in a research note on Tuesday, March 4th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has a consensus rating of &#34;Buy&#34; and an average price target of $20.67.</p>
<div class="lb-trans"><p>VERV 已成為多份研究報告的主題。William Blair 在 2 月 21 日星期五的研究報告中重申了對 Verve Therapeutics 股票的 “跑贏大盤” 評級。HC Wainwright 在 3 月 25 日星期二的報告中重申了 “買入” 評級，並設定了 15.00 美元的目標價。Guggenheim 在 3 月 25 日星期二的研究報告中重申了對 Verve Therapeutics 股票的 “買入” 評級。最後，加拿大皇家銀行在 3 月 4 日星期二的研究報告中將 Verve Therapeutics 的目標價從 17.00 美元下調至 15.00 美元，並對該公司設定了 “跑贏大盤” 評級。五位分析師對該股票給予了買入評級，根據 MarketBeat 的數據，該公司目前的共識評級為 “買入”，平均目標價為 20.67 美元。</p>
</div><p><strong>View Our Latest Analysis on VERV</strong></p>
<div class="lb-trans"><p><strong>查看我們對 VERV 的最新分析</strong></p>
</div><h2>Institutional Investors Weigh In On Verve Therapeutics</h2>
<div class="lb-trans"><h2>機構投資者對 Verve Therapeutics 的看法</h2>
</div><p>A number of hedge funds and other institutional investors have recently bought and sold shares of VERV. BVF Inc. IL boosted its stake in Verve Therapeutics by 962.2% in the fourth quarter. BVF Inc. IL now owns 6,904,050 shares of the company's stock worth $38,939,000 after purchasing an additional 6,254,050 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Verve Therapeutics in the fourth quarter valued at about $7,863,000. Schonfeld Strategic Advisors LLC lifted its position in Verve Therapeutics by 57.4% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 3,789,379 shares of the company's stock worth $21,372,000 after buying an additional 1,382,176 shares in the last quarter. State Street Corp grew its holdings in Verve Therapeutics by 27.0% during the 3rd quarter. State Street Corp now owns 4,253,217 shares of the company's stock worth $20,586,000 after acquiring an additional 903,809 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. grew its holdings in Verve Therapeutics by 72.2% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 1,559,393 shares of the company's stock worth $7,547,000 after acquiring an additional 653,578 shares during the last quarter. 97.11% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些對沖基金和其他機構投資者最近買入和賣出了 VERV 的股票。BVF Inc. IL 在第四季度將其在 Verve Therapeutics 的持股增加了 962.2%。BVF Inc. IL 現在擁有 6,904,050 股公司股票，價值 38,939,000 美元，在上個季度又購買了 6,254,050 股。Point72 Asset Management L.P.在第四季度購買了 Verve Therapeutics 的新頭寸，價值約為 7,863,000 美元。Schonfeld Strategic Advisors LLC 在第四季度將其在 Verve Therapeutics 的持股增加了 57.4%。Schonfeld Strategic Advisors LLC 現在擁有 3,789,379 股公司股票，價值 21,372,000 美元，在上個季度又購買了 1,382,176 股。State Street Corp 在第三季度將其在 Verve Therapeutics 的持股增加了 27.0%。State Street Corp 現在擁有 4,253,217 股公司股票，價值 20,586,000 美元，在上個季度又收購了 903,809 股。最後，Jacobs Levy Equity Management Inc.在第三季度將其在 Verve Therapeutics 的持股增加了 72.2%。Jacobs Levy Equity Management Inc.現在擁有 1,559,393 股公司股票，價值 7,547,000 美元，在上個季度又收購了 653,578 股。97.11% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>About Verve Therapeutics</h2>
<div class="lb-trans"><h2>關於 Verve Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Verve Therapeutics, Inc, a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The company's lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver; and VERVE-102, a product candidate that targets the PCSK9 gene for the treatment of HeFH.</p>
<div class="lb-trans"><p>Verve Therapeutics, Inc.是一家臨牀階段的基因治療公司，致力於開發基因編輯藥物，以治療美國的心血管疾病。該公司的主要產品候選藥物是 VERVE-101，這是一種單次基因編輯治療，能夠永久關閉肝臟中的 PCSK9 基因；以及 VERVE-102，這是一種針對 PCSK9 基因的產品候選藥物，用於治療家族性高膽固醇血癥（HeFH）。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Verve Therapeutics</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>Shares of RH Down Nearly 40%: Where Investors Can Turn To Now</li>
<li>How to Use the MarketBeat Stock Screener</li>
<li>Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian</li>
<li>What Does a Stock Split Mean?</li>
<li>Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Verve Therapeutics 更好</li>
<li>三大醫療股息股票值得購買和持有</li>
<li>RH 的股票下跌近 40%：投資者現在可以轉向哪裏</li>
<li>如何使用 MarketBeat 股票篩選器</li>
<li>關税、分拆和 R2 更新是 Rivian 的積極信號</li>
<li>股票拆分意味着什麼？</li>
<li>Cathie Wood 大量購買百度——現在是購買的合適時機嗎？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 InsiderTrades.com 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 InsiderTrades.com 編輯團隊的審核。如對該故事有任何問題或意見，請發送電子郵件至 [email protected].</em></p>
</div><p>Insider Buying or Selling at Verve Therapeutics?</p>
<div class="lb-trans"><p>Verve Therapeutics 的內部買賣情況？</p>
</div><p>Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Verve Therapeutics and related companies.</p>
<div class="lb-trans"><p>註冊以接收 InsiderTrades.com 關於 Verve Therapeutics 及相關公司的每日內部買賣報告。</p>
</div><p>More From MarketBeat</p>
<div class="lb-trans"><p>來自 MarketBeat 的更多信息</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_elon_new-1.jpg" alt="" original-src="https://www.marketbeat.com/images/webpush/files/thumb_2069push_elon_new-1.jpg"/></p>
<p>DOGE Social Security bombshell?</p>
<div class="lb-trans"><p>DOGE 社會保障的重磅消息？</p>
</div><p>Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...</p>
<div class="lb-trans"><p>埃隆·馬斯克剛剛發佈了另一個重磅消息……他透露他的 DOGE 組織一直在瞄準社會……</p>
</div><p>Altimetry</p>
<div class="lb-trans"><p>Altimetry</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUwOQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=12509&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_Depositphotos_210423878_S.jpg" alt="" original-src="https://www.marketbeat.com/images/webpush/files/thumb_2050push_Depositphotos_210423878_S.jpg"/></p>
<p>7 Stocks to Ride the Autonomous Driving Boom</p>
<div class="lb-trans"><p>7 只股票迎接自動駕駛熱潮</p>
</div><p>The global autonomous vehicle (AV) market is growing. According to the Autonomous Vehicle Industry Association...</p>
<div class="lb-trans"><p>全球自動駕駛汽車（AV）市場正在增長。根據自動駕駛汽車行業協會的數據顯示……</p>
</div><p>MarketBeat</p>
<div class="lb-trans"><p>MarketBeat</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://3328.efuserassets.com/3328/offers/56/c/397/assets/PGC%20-%20Gold%20Guide%20Open%20Layout%20Mockup.png" alt="" original-src="https://3328.efuserassets.com/3328/offers/56/c/397/assets/PGC%20-%20Gold%20Guide%20Open%20Layout%20Mockup.png"/></p>
<p>Your Retirement Is Caught in the Crossfire</p>
<div class="lb-trans"><p>你的退休金正處於交火之中</p>
</div><p>When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...</p>
<div class="lb-trans"><p>當特朗普於 2017 年上任時，黃金的價格僅為每盎司 1100 美元。到他離任時，價格飆升至 1839 美元。...</p>
</div><p>Premier Gold Co</p>
<div class="lb-trans"><p>首選黃金公司</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjQyMQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=12421&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2066push_Depositphotos_235981192_S.jpg" alt="" original-src="https://www.marketbeat.com/images/webpush/files/thumb_2066push_Depositphotos_235981192_S.jpg"/></p>
<p>7 Alcohol Stocks Primed to Pour Profits</p>
<div class="lb-trans"><p>7 只酒類股票準備帶來利潤</p>
</div><p>In 2020 and 2021, alcohol stocks were among the best-performing consumer staples stocks. But it's been a diffe...</p>
<div class="lb-trans"><p>在 2020 年和 2021 年，酒類股票是表現最好的消費品股票之一。但情況有所不同...</p>
</div><p>MarketBeat</p>
<div class="lb-trans"><p>市場快訊</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_elon-musk-6222396_640.jpg" alt="" original-src="https://www.marketbeat.com/images/webpush/files/thumb_2050push_elon-musk-6222396_640.jpg"/></p>
<p>Collect $7k per month from Tesla’s SECRET dividend</p>
<div class="lb-trans"><p>每月從特斯拉的秘密股息中收取 7000 美元</p>
</div><p>Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...</p>
<div class="lb-trans"><p>特斯拉並不支付傳統股息....但我剛剛發現了一個秘密後門，可以收取秘密的 69...</p>
</div><p>Investors Alley</p>
<div class="lb-trans"><p>投資者小巷</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUyMQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=12521&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2068push_Depositphotos_42578405_S.jpg" alt="" original-src="https://www.marketbeat.com/images/webpush/files/thumb_2068push_Depositphotos_42578405_S.jpg"/></p>
<p>7 Uranium Stocks That Can Fuel a Growth Portfolio</p>
<div class="lb-trans"><p>7 只鈾股票可以為增長投資組合提供動力</p>
</div><p>Investing in commodity stocks can be tricky, and uranium stocks are no exception. The spot price of uranium ...</p>
<div class="lb-trans"><p>投資商品股票可能很棘手，鈾股票也不例外。鈾的現貨價格...</p>
</div><p>MarketBeat</p>
<div class="lb-trans"><p>市場快訊</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_bitcoin-3374479_640.jpg" alt="" original-src="https://www.marketbeat.com/images/webpush/files/thumb_2069push_bitcoin-3374479_640.jpg"/></p>
<p>Urgent Bitcoin alert for RIGHT NOW</p>
<div class="lb-trans"><p>緊急比特幣警報，立即關注</p>
</div><p>Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...</p>
<div class="lb-trans"><p>前億萬富翁對沖基金經理拉里·本尼迪克特發佈了他最令人難以置信的演示文稿，內容涉及他的 4...</p>
</div><p>Brownstone Research</p>
<div class="lb-trans"><p>布朗斯通研究</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMjUwMQ" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=12501&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2054push_stocks.jpg" alt="" original-src="https://www.marketbeat.com/images/webpush/files/thumb_2054push_stocks.jpg"/></p>
<p>7 Best Stocks to Own Right Now</p>
<div class="lb-trans"><p>現在擁有的 7 只最佳股票</p>
</div><p>Today, we invite you to view our list of the seven best stocks to own for the next thirty days. Why is it w...</p>
<div class="lb-trans"><p>今天，我們邀請您查看我們為未來三十天推薦的七隻最佳股票。為什麼它們值得關注...</p>
</div><p>MarketBeat</p>
<div class="lb-trans"><p>市場快訊</p>
</div>

Verve Therapeutics, Inc. (NASDAQ:VERV) 內部人士出售了價值 11,524.55 美元的股票